These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12071577)

  • 1. Clinical aspects of Rh genotyping.
    Cotorruelo CM; Biondi CS; García Borrás S; Racca AL
    Clin Lab; 2002; 48(5-6):271-81. PubMed ID: 12071577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed.
    van der Schoot CE; Tax GH; Rijnders RJ; de Haas M; Christiaens GC
    Transfus Med Rev; 2003 Jan; 17(1):31-44. PubMed ID: 12522770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prenatal typing of Rh- and Kell- blood group system antigens].
    Faas BH; Maaskant-van Wijk PA; Beuling EA; Overbeeke MA; van der Schoot CE; Christiaens GC
    Ned Tijdschr Geneeskd; 1999 Sep; 143(36):1804-7. PubMed ID: 10526582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determination of RhD phenotype by DNA typing: clinical applications.
    Cotorruelo C; Biondi C; Borrás SG; Galizzi S; Di Mónaco R; Racca A
    Ann Clin Biochem; 2000 Nov; 37 ( Pt 6)():781-9. PubMed ID: 11085623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
    Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
    J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
    Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
    Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
    Daniels G; Finning K; Martin P; Soothill P
    Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weak D and partial D in Slovenian population through serology and genotyping.
    Rupreht RR; Pretnar Hartman K; Galvani V; Rozman P; Curin Serbec V
    Pflugers Arch; 2000; 440(5 Suppl):R195-6. PubMed ID: 11005669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive fetal RhCE genotyping from maternal blood.
    Geifman-Holtzman O; Grotegut CA; Gaughan JP; Holtzman EJ; Floro C; Hernandez E
    BJOG; 2009 Jan; 116(2):144-51. PubMed ID: 18503573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.
    Geifman-Holtzman O; Grotegut CA; Gaughan JP
    Am J Obstet Gynecol; 2006 Oct; 195(4):1163-73. PubMed ID: 17000250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of RH.
    Flegel WA; Wagner FF
    Vox Sang; 2000; 78 Suppl 2():109-15. PubMed ID: 10938938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advance in the Rh blood group system.
    Kajii E
    Nihon Hoigaku Zasshi; 1998 Feb; 52(1):1-18. PubMed ID: 9591398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison between genotyping and serological phenotyping in RhCE blood group].
    Zhou HY; Zhang YZ; Meng QB; Bai XH; Wang CR; Cao Q; Lan JC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):66-9. PubMed ID: 18247308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
    Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
    Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical utility of fetal cell sorting to determine prenatally fetal E/e or e/e Rh genotype from peripheral maternal blood.
    Geifman-Holtzman O; Makhlouf F; Kaufman L; Gonchoroff NJ; Holtzman EJ
    Am J Obstet Gynecol; 2000 Aug; 183(2):462-8. PubMed ID: 10942488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics of RH and its clinical application.
    Flegel WA
    Transfus Clin Biol; 2006; 13(1-2):4-12. PubMed ID: 16563832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal RhD genotyping by maternal serum analysis: a two-year experience.
    Gautier E; Benachi A; Giovangrandi Y; Ernault P; Olivi M; Gaillon T; Costa JM
    Am J Obstet Gynecol; 2005 Mar; 192(3):666-9. PubMed ID: 15746656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.